Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of remimazolam with sufentanil and lidocaine for painless gastroscopy in elderly patients
ChiCTR2200063787Phase 4Not yet recruiting
- Sponsor
- Ya'an People's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam (3 arms), sponsored by Ya'an People's Hospital. Primary endpoint: Remimazolam ED50 and ED95. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200063787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063787.